| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,211 |
5,099 |
$552K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,636 |
5,428 |
$427K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
385 |
385 |
$37K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
648 |
634 |
$32K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
152 |
152 |
$22K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
709 |
709 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
1,933 |
1,876 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
699 |
690 |
$10K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
96 |
95 |
$8K |
| 81025 |
|
687 |
674 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
183 |
183 |
$5K |
| 90686 |
|
353 |
353 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
125 |
124 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
27 |
27 |
$939.40 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17 |
15 |
$843.62 |
| 90656 |
|
36 |
36 |
$544.18 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
29 |
29 |
$447.48 |